Scientific work

Prof. Dr. Aysun Soysal

254 publications. The source of the information is stated next to each publication.

Back to profile

  1. Prolonged Median Motor Distal Latency: What If not Carpal Tunnel Syndrome but Acute Inflammatory Demyelinating Polyradiculoneuropathy?

    Neurological Sciences and Neurophysiology, 2024

    DOI 10.4103/nsn.nsn_117_24 Open-access full textSource: ORCID

  2. Routine CSF parameters as predictors of disease course in multiple sclerosis: An MSBase cohort study

    Journal of Neurology Neurosurgery and Psychiatry, 2024

    DOI 10.1136/jnnp-2023-333307 PMID 38569872 8 citations (Europe PMC) Open-access full textSource: ORCID

  3. The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study

    Therapeutic Advances in Neurological Disorders, 2024

    DOI 10.1177/17562864241278496 PMID 39525878 5 citations (Europe PMC) Open-access full textSource: ORCID

  4. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

    Lancet Child and Adolescent Health, 2024

    DOI 10.1016/s2352-4642(24)00047-6 PMID 38547883 34 citations (Europe PMC) Open-access full textSource: ORCID

  5. Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study

    CNS Drugs, 2024

    DOI 10.1007/s40263-024-01115-x PMID 39242483 1 citation (Europe PMC) Open-access full textSource: ORCID

  6. 3018 A multi-centre longitudinal study analysing disease modifying therapy prescribing patterns during the COVID-19 pandemic

    BMJ Neurology Open, 2024

    DOI 10.1136/bmjno-2024-anzan.45 Open-access full textSource: OpenAlex

  7. A Journey from Transient Neurological Deficits to a Genetic Diagnosis: CADASIL Case Report

    Neuroscience Applied, 2024

    DOI 10.1016/j.nsa.2024.104717 Open-access full textSource: OpenAlex

  8. From diagnosis to recovery: a rare case of opsoclonus-myoclonus syndrome in an adult successfully treated with IVIg

    Neuroscience Applied, 2024

    DOI 10.1016/j.nsa.2024.104345 Open-access full textSource: OpenAlex

  9. A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry

    Neurodegenerative Disease Management, 2023

    DOI 10.2217/nmt-2023-0005 PMID 37287269 Open-access full textSource: ORCID

  10. Comparative effectiveness in multiple sclerosis: A methodological comparison

    Multiple Sclerosis Journal, 2023

    DOI 10.1177/13524585231151394 PMID 36800908 4 citations (Europe PMC) Open-access full textSource: ORCID

  11. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry

    Multiple Sclerosis Journal, 2023

    DOI 10.1177/13524585221137502 PMID 36433775 32 citations (Europe PMC) Open-access full textSource: ORCID

  12. Disability accrual in primary and secondary progressive multiple sclerosis

    Journal of Neurology Neurosurgery and Psychiatry, 2023

    DOI 10.1136/jnnp-2022-330726 PMID 37068931 6 citations (Europe PMC) Open-access full textSource: ORCID

  13. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

    Multiple Sclerosis Journal, 2023

    DOI 10.1177/13524585231151951 PMID 36851894 15 citations (Europe PMC) Open-access full textSource: ORCID

  14. Enhancement of motor skill acquisition by intermittent theta burst stimulation: a pilot study

    Acta Neurologica Belgica, 2023

    DOI 10.1007/s13760-022-02155-0 PMID 36508110 2 citations (Europe PMC) Source: ORCID

  15. External validation of a clinical prediction model in multiple sclerosis

    Multiple Sclerosis Journal, 2023

    DOI 10.1177/13524585221136036 PMID 36448727 3 citations (Europe PMC) Source: ORCID

  16. Non-invasive brain stimulation on clinical symptoms in multiple sclerosis patients: A systematic review and meta-analysis

    Multiple Sclerosis and Related Disorders, 2023

    DOI 10.1016/j.msard.2023.104927 PMID 37595371 22 citations (Europe PMC) Source: ORCID

  17. Predictors of treatment switching in the Big Multiple Sclerosis Data Network

    Frontiers in Neurology, 2023

    DOI 10.3389/fneur.2023.1274194 PMID 38187157 9 citations (Europe PMC) Open-access full textSource: ORCID

  18. Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5588 PMID 36945929 Open-access full textSource: ORCID

  19. Risk of secondary progressive multiple sclerosis after early worsening of disability

    Journal of Neurology Neurosurgery and Psychiatry, 2023

    DOI 10.1136/jnnp-2023-331748 PMID 37414538 14 citations (Europe PMC) Source: ORCID

  20. Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

    JAMA Neurology, 2023

    DOI 10.1001/jamaneurol.2023.1625 PMID 37307006 60 citations (Europe PMC) Open-access full textSource: ORCID

  21. The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis

    Neurological Sciences, 2023

    DOI 10.1007/s10072-023-06608-z PMID 36689010 17 citations (Europe PMC) Open-access full textSource: ORCID

  22. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

    Brain, 2023

    DOI 10.1093/brain/awad218 PMID 37369086 22 citations (Europe PMC) Open-access full textSource: ORCID

  23. Trigeminal Neuralgia Associated with Vagus Nerve Stimulation: A Case Presentation and Literature Review

    Archives of Epilepsy, 2023

    DOI 10.4274/archepilepsy.2023.23101 Open-access full textSource: ORCID

  24. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

    European Journal of Neurology, 2023

    DOI 10.1111/ene.15706 PMID 36692895 8 citations (Europe PMC) Open-access full textSource: ORCID

  25. Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

    JAMA Neurology, 2023

    DOI 10.1001/jamaneurol.2023.1184 PMID 37437240 61 citations (OpenAlex) Open-access full textSource: OpenAlex

  26. The Comparison of General Characteristics and Early and Late Post-intervention Results in Patients With Trigeminal Neuralgia Secondary to Multiple Sclerosis and Idiopathic Trigeminal Neuralgia Treated With Radiofrequency Thermocoagulation

    Cureus, 2023

    DOI 10.7759/cureus.44810 PMID 37809255 9 citations (OpenAlex) Open-access full textSource: OpenAlex

  27. MSMilan2023 – Oral Presentations

    Multiple Sclerosis Journal, 2023

    DOI 10.1177/13524585231196191 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  28. TH-153. Clinical and electrophysiological characteristics of Guillain-Barré Syndrome before and during the pandemic: The multicenter Istanbul study

    Clinical Neurophysiology, 2022

    DOI 10.1016/j.clinph.2022.07.333 Source: OpenAlex

  29. Autoimmune encephalitis and paraneoplastic syndromes in Turkey: a multi-centre study

    Neurological Sciences, 2022

    DOI 10.1007/s10072-022-05955-7 PMID 35211811 4 citations (Europe PMC) Open-access full textSource: ORCID

  30. Confirmed disability progression as a marker of permanent disability in multiple sclerosis

    European Journal of Neurology, 2022

    DOI 10.1111/ene.15406 PMID 35582938 10 citations (Europe PMC) Open-access full textSource: ORCID

  31. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

    Neurology, 2022

    DOI 10.1212/wnl.0000000000201029 PMID 35977837 49 citations (Europe PMC) Open-access full textSource: ORCID

  32. Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry

    Journal of Neurology Neurosurgery and Psychiatry, 2022

    DOI 10.1136/jnnp-2022-329713 PMID 36180218 4 citations (Europe PMC) Source: ORCID

  33. Four-year Experience of Intravenous and Endovascular Treatment in Acute Ischemic Stroke: A Single Center Study,Akut İskemik İnmede İntravenöz ve Endovasküler Tedavi Deneyimlerimiz: Dört Yıllık Tek Merkez Çalışma

    Turk Noroloji Dergisi, 2022

    DOI 10.4274/tnd.2022.33733 1 citation (OpenAlex) Open-access full textSource: ORCID

  34. Ischemic stroke due to spontaneous reversible extra-cranial internal carotid artery vasospasm: A case report

    Neurology Asia, 2022

    DOI 10.54029/2022vmm 2 citations (OpenAlex) Open-access full textSource: ORCID

  35. Machine-Learning-Based Prediction of Disability Progression in Multiple Sclerosis: An Observational, International, Multi-Center Study

    Ssrn, 2022

    DOI 10.2139/ssrn.4245135 Source: ORCID

  36. Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study

    Medrxiv, 2022

    DOI 10.1101/2022.09.08.22279617 Open-access full textSource: ORCID

  37. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

    Multiple Sclerosis Journal, 2022

    DOI 10.1177/13524585221084577 PMID 35373638 4 citations (Europe PMC) Open-access full textSource: ORCID

  38. Predictive Analysis of Errors During Robot-Mediated Gamified Training

    IEEE International Conference on Rehabilitation Robotics, 2022

    DOI 10.1109/icorr55369.2022.9896589 PMID 36176135 Open-access full textSource: ORCID

  39. Restless legs syndrome after acute ıschemic stroke and ıts relation to lesion location

    Sleep and Biological Rhythms, 2022

    DOI 10.1007/s41105-022-00401-9 PMID 38468622 3 citations (Europe PMC) Open-access full textSource: ORCID

  40. The minnesota manual dexterity test as a bimanual performance measure in people with multiple sclerosis

    Multiple Sclerosis and Related Disorders, 2022

    DOI 10.1016/j.msard.2022.103943 PMID 35738113 10 citations (Europe PMC) Source: ORCID

  41. Real-world Comparative Effectiveness and Persistence of Cladribine Tablets and Other Oral Disease-Modifying Treatments for Multiple Sclerosis from GLIMPSE: Results from the MSBase Registry (P12-4.003)

    Neurology, 2022

    DOI 10.1212/wnl.98.18_supplement.1373 4 citations (OpenAlex) Source: OpenAlex

  42. Enjeksiyon Nöropatisi Olgularında Siyatik Sinir Tutulumunun ve Derecesinin Değerlendirilmesi

    Dicle Medical Journal / Dicle Tip Dergisi, 2022

    DOI 10.5798/dicletip.1086306 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  43. Early Predictors of Disability in Paediatric Multiple Sclerosis: Evidence from a Multi-National Registry (P17-4.001)

    Neurology, 2022

    DOI 10.1212/wnl.98.18_supplement.2668 Source: OpenAlex

  44. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

    Movement Disorders, 2021

    DOI 10.1002/mds.28518 PMID 33624863 13 citations (Europe PMC) Source: OpenAlex

  45. Central nervous system vasculitis due to an endemic zoonosis in turkey; tularemia,Ülkemizde endemik bir zoonoz nedeni; tularemi?ye bağli santral sinir sistemi vasküliti

    Noropsikiyatri Arsivi, 2021

    DOI 10.29399/npa.23491 PMID 33795957 1 citation (Europe PMC) Open-access full textSource: ORCID

  46. Determinants of therapeutic lag in multiple sclerosis

    Multiple Sclerosis Journal, 2021

    DOI 10.1177/1352458520981300 PMID 33423618 4 citations (Europe PMC) Open-access full textSource: ORCID

  47. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

    Multiple Sclerosis Journal, 2021

    DOI 10.1177/1352458520926955 PMID 32538713 11 citations (Europe PMC) Open-access full textSource: ORCID

  48. Fluctuating Pupil-sparing Oculomotor Nerve Palsy with Intracranial Spontaneous Dissecting Aneurysm,İntrakraniyal Spontan Dissekan Anevrizmaya Bağlı Fluktuasyon Gösteren Okulomotor Sinir Felci

    Turk Noroloji Dergisi, 2021

    DOI 10.4274/tnd.2021.47700 Open-access full textSource: ORCID

  49. Investigation of oxidative stress in relapse and remission periods of patients with relapsing-remitting multiple sclerosis

    Neurological Sciences and Neurophysiology, 2021

    DOI 10.4103/nsn.nsn_142_20 2 citations (OpenAlex) Open-access full textSource: ORCID

  50. Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry

    Journal of the Neurological Sciences, 2021

    DOI 10.1016/j.jns.2021.118067 PMID 34537678 12 citations (Europe PMC) Open-access full textSource: ORCID